Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: A prospective cohort study of Air Force veterans

Urology

Volumn 68, Issue 6, 2006, Pages 1198-1205

  Gupta, Amit ^a   Gupta, Sachin ^a   Pavuk, Marian ^b   Roehrborn, Claus G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b AIR FORCE RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIR FORCE; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; VETERAN;

AGE FACTORS; BODY CONSTITUTION; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIPIDS; MALE; MIDDLE AGED; MILITARY PERSONNEL; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; RISK FACTORS; THYROID HORMONES; TIME FACTORS; UNITED STATES; VETERANS; VIETNAM CONFLICT;

EID: 33845308799     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.09.034     Document Type: Article

References (29)

1. Dahle S.E., Chokkalingam A.P., Gao Y.T., et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 168 (2002) 599-604
2. Giovannucci E., Rimm E.B., Chute C.G., et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 140 (1994) 989-1002
3. Hammarsten J., Hogstedt B., Holthuis N., et al. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1 (1998) 157-162
4. Lee S., Min H.G., Choi S.H., et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity (Silver Spring) 14 (2006) 172-179
5. Parsons J.K., Carter H.B., Partin A.W., et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 91 (2006) 2562-2568
6. Rohrmann S., Smit E., Giovannucci E., et al. Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 159 (2004) 390-397
7. Zhuang T.N., Ly L.P., Cumming R.G., et al. Growth and development during early manhood as determinants of prostate size in later life. J Clin Endocrinol Metab 90 (2005) 6055-6063
8. Glynn R.J., Campion E.W., Bouchard G.R., et al. The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 121 (1985) 78-90
9. Zucchetto A., Tavani A., Dal Maso L., et al. History of weight and obesity through life and risk of benign prostatic hyperplasia. Int J Obes (Lond) 29 (2005) 798-803
10. Burke J.P., Rhodes T., Jacobson D.J., et al. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. Am J Epidemiol 164 (2006) 41-46
11. Gann P.H., Hennekens C.H., Longcope C., et al. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 26 (1995) 40-49
12. Meigs J.B., Mohr B., Barry M.J., et al. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54 (2001) 935-944
13. Morrison A.S. Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol 135 (1992) 974-980
14. Seitter W.R., and Barrett-Connor E. Cigarette smoking, obesity, and benign prostatic hypertrophy: a prospective population-based study. Am J Epidemiol 135 (1992) 500-503
15. Joseph M.A., Harlow S.D., Wei J.T., et al. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol 157 (2003) 906-914
16. Rohrmann S., Smit E., Giovannucci E., et al. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) 29 (2005) 310-316
17. Wolfe W.H., Michalek J.E., Miner J.C., et al. Health status of Air Force veterans occupationally exposed to herbicides in Vietnam. I. Physical health. JAMA 264 (1990) 1824-1831
18. Gupta A., Ketchum N., Roehrborn C.G., et al. Serum dioxin, testosterone, and subsequent risk of benign prostatic hyperplasia: a prospective cohort study of Air Force Veterans. Environ Health Perspect 114 (2006) 1649-1654
19. Pavuk M., Schecter A.J., Akhtar F.Z., et al. Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) levels and thyroid function in Air Force veterans of the Vietnam War. Ann Epidemiol 13 (2003) 335-343
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
21. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 29 suppl 1 (2006) S43-S48
22. Ogden C.L., Fryar C.D., Carroll M.D., et al. Mean body weight, height, and body mass index, United States 1960-2002. Adv Data 347 (2004) 1-17
23. Roehrborn C.G., McConnell J., Bonilla J., et al., PROSCAR Long-Term Efficacy and Safety Study. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. J Urol 163 (2000) 13-20
24. Sarma A.V., Jaffe C.A., Schottenfeld D., et al. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among black men. Urology 59 (2002) 362-367
25. Michel M.C., Heemann U., Schumacher H., et al. Association of hypertension with symptoms of benign prostatic hyperplasia. J Urol 172 (2004) 1390-1393
26. McVary K.T., Razzaq A., Lee C., et al. Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod 51 (1994) 99-107
27. McVary K.T., Rademaker A., Lloyd G.L., et al. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 174 (2005) 1327-1333
28. Lehrer S., Diamond E.J., Stone N.N., et al. Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia. J Urol 168 (2002) 2431-2433
29. Rohrmann S., De Marzo A.M., Smit E., et al. Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III). Prostate 62 (2005) 27-33